Pioneering Robotic Innovation in Neurovascular Surgery
Navigantis has announced the first successful clinical cases using its Vasco interventional robotic platform for neurovascular procedures. The Miami-based company designed Vasco to treat complex neurovascular disorders, including acute ischemic stroke, marking a significant milestone in surgical robotics.
Clinical Trial Highlights:
- Applications: Includes diagnostic cerebral angiograms, brain tumor embolization, and mechanical thrombectomy for ischemic stroke.
- Leadership: Led by Dr. Dong Joon Kim at Severance Hospital, Seoul, South Korea.
- Previous Success: Vasco’s earlier generation performed robotic embolization of liver tumors in 2022.
Advancing Neurovascular Care
“These first robotic cases are a major stepping stone towards treating more complex neurovascular diseases,” said Dr. Kim.
Navigantis emphasizes its mission to enable “uncompromised neurovascular care” through robotic innovation.
Future Potential for Robotic Telesurgery
CEO Mor Dayan highlighted the broader implications:
“The Vasco robotic platform could redefine the approach to time-sensitive neurovascular procedures. Robotic telesurgery for stroke patients could significantly reduce response times and expand access to critical care.”
Navigantis continues to push the boundaries of surgical robotics, aiming to enhance patient outcomes and procedural efficiency in the most challenging neurovascular cases.
Follow MEDWIRE.AI for updates on robotics transforming healthcare
